Deutsche Bank
FOMX

Deutsche Bank’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Deutsche Bank’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,898
Closed -$33K – 5232
2019
Q3 		$33K Sell
10,898
-178,613
-94% -$502K ﹤0.01% 4129
2019
Q2 		$450K Buy
189,511
+175,930
+1,295% +$526K ﹤0.01% 3339
2019
Q1 		$50K Buy
+13,581
New +$50.9K ﹤0.01% 4562
2018
Q4 		– Sell
-5,870
Closed -$34K – 5573
2018
Q3 		$34K Sell
5,870
-24,696
-81% -$141K ﹤0.01% 4810
2018
Q2 		$153K Buy
30,566
+20,001
+189% +$103K ﹤0.01% 4392
2018
Q1 		$54K Buy
10,565
+1,859
+21% +$11.2K ﹤0.01% 4734
2017
Q4 		$52K Sell
8,706
-8,436
-49% -$50.8K ﹤0.01% 4436
2017
Q3 		$94K Sell
17,142
-91,080
-84% -$470K ﹤0.01% 4188
2017
Q2 		$502K Buy
108,222
+60,324
+126% +$269K ﹤0.01% 3445
2017
Q1 		$236K Buy
47,898
+27,261
+132% +$262K ﹤0.01% 3505
2016
Q4 		$229K Sell
20,637
-6,632
-24% -$62.4K ﹤0.01% 3596
2016
Q3 		$252K Sell
27,269
-62,396
-70% -$522K ﹤0.01% 3540
2016
Q2 		$569K Buy
89,665
+35,586
+66% +$236K ﹤0.01% 3210
2016
Q1 		$351K Sell
54,079
-4,090
-7% -$26.4K ﹤0.01% 3391
2015
Q4 		$470K Sell
58,169
-13,637
-19% -$102K ﹤0.01% 3307
2015
Q3 		$524K Buy
71,806
+19,797
+38% +$202K ﹤0.01% 3336
2015
Q2 		$532K Buy
+52,009
New +$575K ﹤0.01% 3363
2015
Q1 		– Sell
-34,499
Closed -$241K – 6209
2014
Q4 		$241K Buy
34,499
+1,890
+6% +$10.8K ﹤0.01% 4200
2014
Q3 		$177K Buy
+32,609
New +$187K ﹤0.01% 4150

Other funds holding FOMX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Deutsche Bank's FOMX Position: Q4 2019 in Review

Deutsche Bank sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2019, closing a stake of 10,898 shares — an estimated $33K sold.

Deutsche Bank first reported a position in FOMX in Q3 2014 and held it in 19 quarters. The position peaked at $569K in Q2 2016. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

  • Deutsche Bank reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Deutsche Bank sold 10,898 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $33K.
  • Deutsche Bank first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 19 quarters.
  • Deutsche Bank's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $569K in Q2 2016.
  • 65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.